Super-powered immune cells to attack tumors
The phase 1 clinical trial will test the feasibility and safety of CAR-T cells - genetically modified white blood cells harvested from a patient's own blood with the unique ability to directly attack and kill cancers - to treat advanced solid tumors including small cell lung cancer, sarcomas and triple negative breast cancer.
More... |
All times are GMT -7. The time now is 08:15 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021